Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenip Plc Regulatory News (GNIP)

Share Price Information for Genip Plc (GNIP)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.00 (0.00%)
Bid:
4.50
Ask:
4.80
Spread: 0.30 (6.667%)
Market Cap: £1.19m
GNIP Live PriceLast checked at - London Stock Exchange

Intraday Genip Plc Share Chart

Total Voting Rights

29 May 2026 17:52

RNS Number : 3215G
GenIP PLC
29 May 2026
 

29 May 2026

GenIP Plc

("GenIP" or the "Company")

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules ("DTRs") of the Financial Conduct Authority (the "FCA"), GenIP Plc (AIM:GNIP), a technology consultancy providing AI-driven services to help research organisations and corporations commercialise their innovations, announces that as at the date of this announcement the Company's total issued share capital consists of 25,517,461 ordinary shares of £0.00425 with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury and accordingly there are no voting rights in respect of any treasury shares. 

The abovementioned figure of 25,517,461 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, GenIP under the FCA's DTRs.

ENDS

 

For further information regarding GenIP, please visit www.genip.ai, or contact:

 

GenIP Plc

Melissa Cruz, CEO 

Via Redchurch Communications

Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish / Asia Szusciak

 

 

Tel: +44 (0) 20 7628 3396

 

AlbR Capital Limited (Broker) 

Colin Rowbury

Jon Belliss

Tel: +44 (0) 20 7399 9427

cr@albrcapital.com 

Jb@albrcapital.com

 

CMC Markets (Joint Broker)

Douglas Crippen

 

Tel: +44 (0) 20 3003 8632

Redchurch Communications (Financial PR)

John Casey

 

 

genip@weareredchurch.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRPPURCAUPQGQB
Date   Source Headline
24th Jun 20265:18 pmRNSResult of AGM
24th Jun 20267:00 amRNS-RGenIP Innovation Roundtable
29th May 20265:52 pmRNSTotal Voting Rights
27th May 20267:00 amRNSAudited Final Results FY25 and Notice of AGM
21st May 20267:00 amRNSNew Orders
5th May 202611:35 amRNSTR-1: Notification of major holdings
1st May 20267:00 amRNSShare Placing to raise £350,000 and TVR
28th Apr 20267:00 amRNSStrategic Resale Alliance with Cardinal IP
31st Mar 20267:00 amRNS-RCommercial Update
10th Feb 20267:00 amRNS-RSales and Product Update
15th Jan 20267:00 amRNSCorporate Update
4th Dec 20257:00 amRNSOperational Update, Placing and TVR
21st Nov 20257:00 amRNS-RNew Report Orders From Repeat Clients
13th Nov 20257:00 amRNSTrading Statement
15th Oct 20257:00 amRNS-RTechnology Park Alliance
10th Oct 20257:00 amRNSNew Product Launch – Invention Validator
6th Oct 20257:00 amRNSReplacement RNS: Half-year Report
30th Sep 20257:02 amRNSCommercial Strategy Update & New Products
30th Sep 20257:00 amRNSHalf-year Report
24th Sep 20257:00 amRNS-RStrategic Partnership
15th Sep 20257:00 amRNS-RStrategic Partnership
25th Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNS-RGenIP Secures First UK Academic Clients
26th Jun 20255:07 pmRNSResult of AGM
10th Jun 20257:00 amRNSContract Win
4th Jun 20257:00 amRNSAudited Results for Period Ended 31 December 2024
2nd Jun 20256:27 pmRNSNotice of AGM
29th May 20257:00 amRNS-RBusiness Update
7th May 20257:00 amRNS-RGenIP to attend 2025 AUTM Canadian Region Meeting
1st May 20257:00 amRNS-RNew Product Launch
31st Mar 20255:34 pmRNSUnaudited Results to 31 December 2024
26th Mar 20257:00 amRNS-RContract Win
20th Mar 20257:00 amRNS$0.35m Contract Win
13th Mar 20257:00 amRNSCorporate Update & 2025 Outlook
11th Feb 20257:00 amRNS-RGenIP to Sponsor the AUTM 2025 Annual Meeting
3rd Dec 20245:29 pmRNSTR-1: Notification of major holdings
20th Nov 20247:00 amRNSCorporate Update
8th Oct 20247:00 amRNSCorporate Update
2nd Oct 20247:00 amRNSAdmission to Trading on AIM-First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.